Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001102624-13-000604
Filing Date
2013-05-14
Accepted
2013-05-14 16:11:56
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 AEOLUS PHARMACEUTICALS, INC. 10-K/A aeolus10k.htm 10-K/A 1918218
2 EXHIBIT 23.1 exh23_1.htm EX-23.1 3724
3 EXHIBIT 31.1 exh31_1.htm EX-31.1 15427
4 EXHIBIT 31.2 exh31_2.htm EX-31.2 15477
5 EXHIBIT 32.1 exh32_1.htm EX-32.1 14032
  Complete submission text file 0001102624-13-000604.txt   6639124

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aols-20120930.xml EX-101.INS 1040273
7 XBRL TAXONOMY EXTENSION SCHEMA aols-20120930.xsd EX-101.SCH 39026
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aols-20120930_cal.xml EX-101.CAL 29989
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aols-20120930_def.xml EX-101.DEF 66656
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aols-20120930_lab.xml EX-101.LAB 239844
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aols-20120930_pre.xml EX-101.PRE 175846
Mailing Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691
Business Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691 9494819825
AEOLUS PHARMACEUTICALS, INC. (Filer) CIK: 0001261734 (see all company filings)

EIN.: 561953785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-50481 | Film No.: 13841688
SIC: 2834 Pharmaceutical Preparations